Gelonghui April 25 丨 Kangchen Pharmaceutical (603590)(603590playtoearncryptogamesmobile.SH) releases 2023 annual reportplaytoearncryptogamesmobileIn 2023, the company achieved operating income of 920 million yuan, an increase of 6.15% over the same period last year; net profit attributable to owners of the parent company was 150 million yuan, an increase of 48.24% over the same period last year; net profit attributable to owners of the parent company after deducting non-recurring gains and losses was 127 million yuan, an increase of 42.51% over the same period last year; basic earnings per share was 0.96 yuan. It is planned to distribute a cash dividend of RMB 3.00 (including tax) to all shareholders for every 10 shares.
